Looks likely they may have run out of time over Christmas and New Year to get through the 17,000 pages of info. There's no provision for the FDA to gain additional time other than through a clinical hold.
Ordinarily, if the FDA has questions / clarifications, you'd hear about this during the assessment period.
Perplexing to say the least!
Cheers
Densy
Ann: Neurizon updates on NUZ-001 IND Application, page-3
-
- There are more pages in this discussion • 255 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $81.23M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 17.0¢ | 15.5¢ | $193.8K | 1.191M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 78264 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 49399 | 3 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |